Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Polyene, binds ergosterol and induces membrane ...
Calcitonin-family peptide, involved in vasodila...
Selective inhibitor of c-Met.
NSAID; COX-2 inhibitor.
MDM2 inhibitor.
Endogenous steroid hormone, involved in regulat...
Mycotoxin produced by species of Aspergillus; D...
SIRT inhibitor.
CDK2 inhibitor.
Microtubule depolymerization inhibitor.
Cephalotaxine alkaloid originally found in Ceph...
RARα/β agonist.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Peptide, GLP-1 analog found in Heloderma; GLP-1...
Synthetic antifungal.
Statin; HMG-CoA reductase inhibitor, potential ...
Piroxicam prodrug, NSAID; COX-1/2 inhibitor.
BK K+ channel and L-type Ca2+ channel blocker.<...
PI3K and PDK1 inhibitor.